米国の腱修復市場規模、シェア、動向分析レポート：用途別、製品タイプ別、セグメント別予測、2024年～2030年

米国の腱修復市場の成長と動向：

Grand View Research社の最新レポートによると、米国の腱修復市場規模は2030年までに11億5,000万米ドルに達すると予測され、2024年から2030年までのCAGRは8.0％で成長すると予測されています。

米国における老人人口の増加も手伝って、軟部組織の損傷を示す高齢化人口の増加が腱修復市場の成長を促進しています。例えば、米国国勢調査局によると、米国の65歳以上の成人は5,600万人を超え、総人口の約16.9％を占めています。さらに、2030年までには、その数は7,310万人に増加し、およそ5人に1人になると予想されています。

また、より多くの人が何らかの形で身体活動に参加しているため、スポーツ関連の怪我も増加傾向にあります。スポーツの性質上、プロのアスリート、特に高齢のアスリートは、腱などの軟部組織の断裂や捻挫を起こしやすいです。ジョンズ・ホプキンス医学が発表した論文によると、約3,000万人が何らかの組織化されたスポーツに参加しており、米国では毎年350万人以上のスポーツ外傷が発生しており、中でも捻挫や挫傷が最も多いです。

筋骨格系疾患は、米国では18歳以上の2人に1人、65歳以上の4人に3人近くが罹患しています。外傷、腰痛、関節炎は、最も一般的に報告されている3つの筋骨格系疾患であり、毎年数百万人が医院、救急室、病院を訪れています。

さらに、最近の整形外科手術の進歩やアプローチは、軟部組織損傷の管理に革命をもたらしました。断裂した腱を含む軟部組織損傷のほとんどは、外科的修復と、凍結療法や物理的リハビリテーションのような生物物理学的手法を含む保存的アプローチで治療されています。先進的な腱や靭帯の修復ソリューションを導入する主な市場プレイヤーの最近の発展は、市場の拡大をさらに促進しました。例えば、2023年1月、Zimmer Biomet社は、靭帯・腱修復用コラーゲンベースインプラントの開発企業であるEmbody社の買収を計画しています。

米国の腱修復市場レポート・ハイライト

• 用途別では、スポーツ関連傷害の増加や高齢者人口の増加により、腱板修復分野が2023年に37.6%の最大市場シェアを占めました。
• 製品タイプ別では、インプラントは回復が早く、インプラントに関連する適合性の問題が少ないことから、腱修復市場で最も速いCAGRで成長すると予測されています。
• 縫合糸アンカーデバイス部門は、縫合糸アンカーデバイスの強度が高いため、2023年に最大の収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の腱修復市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国腱修復市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の腱修復市場：予定の推定・動向分析

• 予定市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別米国腱修復市場の見通し
• 以下の市場規模、予測および動向分析、2018年～2030年
  • 腱板修復
  • アキレス腱炎の修復
  • 十字靭帯の修復
  • 上腕二頭筋の腱鞘炎
  • その他

第5章 米国の腱修復市場：製品タイプの推定・動向分析

• 製品タイプの市場シェア、2023年および2030年
• セグメントダッシュボード
• 製品タイプ別の世界の米国腱修復市場の見通し
• 以下の市場規模、予測および動向分析、2018年～2030年
  • インプラント
  • 縫合糸アンカー装置
  • 移植片
  • マトリックス/足場
  • ネジ
  • その他

第6章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Integra LifeSciences
  • Arthrex, Inc.
  • TendoMend
  • DePuy Synthes, Inc.
  • CONMED Corporation.
  • Stryker
  • BioPro, Inc.
  • Parcus Medical（Anika Therapeutics, Inc.）
  • Aevumed, Inc.
  • Smith+Nephew.
  • Alafair Biosciences, Inc.
  • Amniotics AB
  • BioTissue
  • MiMedx

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. Tendon Repair market, by application, 2018 - 2030 (USD Million)
• Table 3 U.S. Tendon Repair market, by product type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. Tendon Repair market: market outlook
• Fig. 9 U.S. Tendon Repair competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. Tendon Repair market driver impact
• Fig. 15 U.S. Tendon Repair market restraint impact
• Fig. 16 U.S. Tendon Repair market strategic initiatives analysis
• Fig. 17 U.S. Tendon Repair market: Application movement analysis
• Fig. 18 U.S. Tendon Repair market: Application outlook and key takeaways
• Fig. 19 Rotator cuff repair market estimates and forecast, 2018 - 2030
• Fig. 20 Achilles tendinosis Repair market estimates and forecast, 2018 - 2030
• Fig. 21 Cryoablation market estimates market and forecast, 2018 - 2030
• Fig. 22 Cruciate ligaments Repair estimates and forecast, 2018 - 2030
• Fig. 23 Biceps tenodesis market estimates and forecast, 2018 - 2030
• Fig. 24 Others estimates and forecast, 2018 - 2030
• Fig. 25 U.S. Tendon Repair Market: Product type movement Analysis
• Fig. 26 U.S. Tendon Repair market: Product type outlook and key takeaways
• Fig. 27 Implants market estimates and forecasts, 2018 - 2030
• Fig. 28 Suture anchor devices market estimates and forecasts,2018 - 2030
• Fig. 29 Grafts market estimates and forecasts,2018 - 2030
• Fig. 30 Matrix/scaffolds market estimates and forecasts, 2018 - 2030
• Fig. 31 Tendon repair matrix/scaffolds market estimates and forecasts, 2018 - 2030
• Fig. 32 Tendon protection matrix/scaffolds market estimates and forecasts, 2018 - 2030
• Fig. 33 Screws market estimates and forecasts, 2018 - 2030
• Fig. 34 Others market estimates and forecasts, 2018 - 2030
• Fig. 35 Market share of key market players: U.S. Tendon Repair market

U.S. Tendon Repair Market Growth & Trends:

The U.S. tendon repair market size is anticipated to reach USD 1.15 billion by 2030 and it is projected to grow at a CAGR of 8.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of aging populations witnessing soft tissue injuries aided by rising geriatric population in the U.S. is propelling the growth of the tendon repair market. For instance, according to the U.S. Census Bureau, over 56 million adults 65 and older in the U.S., account for approximately 16.9% of the total population. Moreover, by 2030, the number is expected to rise to 73.1 million, around 1 in every five people.

Sports-related injuries are also on the rise as more people participate in some form of physical activity. Due to the nature of the sport, professional athletes, particularly older athletes, are more prone to tendons and other soft tissue tears and sprains. According to an article published by Johns Hopkins Medicine, approximately 30 million people take part in some organized sports, accounting for more than 3.5 million sports injuries each year in the U.S., with sprains and strains being the most common.

In addition, musculoskeletal diseases are a significant contributor to the patient pool in the U.S. Musculoskeletal diseases affect nearly one out of every two people in the U.S. aged 18 and up and nearly three out of every four people aged 65 and up. Trauma, back pain, and arthritis are the three most common musculoskeletal conditions reported, with millions of visits to doctors' offices, emergency rooms, and hospitals each year.

Moreover, recent advancements and approaches in orthopedic procedures brought a revolution in the management of soft tissue injuries. Most of the soft tissue injuries, including torn tendons, are treated with surgical repair and conservative approaches, including biophysical modalities like cryotherapy & physical rehabilitation. Recent developments by key market players to introduce advanced tendon and ligament repair solutions further facilitated market expansion. For instance, in January 2023, Zimmer Biomet planned to acquire Embody, a developer of collagen-based implants for ligament and tendon repair.

U.S. Tendon Repair Market Report Highlights:

• Based on application, the rotator cuff repair segment held the largest market share of 37.6% in 2023 owing to the rising prevalence of sports related injuries and the geriatric population
• Based on product type, the implants segment is anticipated to grow at the fastest CAGR in the tendon repair market attributed to the faster recovery and less compatible issues associated with implants
• Suture anchor devices segment accounted for largest revenue share in 2023 due to the higher strength of suture anchor devices

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Product Type
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Product type outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Tendon Repair Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing target population
    • 3.2.1.2. Rising incidence of sports-related injuries
    • 3.2.1.3. Advancements in sports medicine
    • 3.2.1.4. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Availability of alternative treatment
    • 3.2.2.2. Stringent regulatory procedures
• 3.3. U.S. Tendon Repair Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Tendon Repair Market: Application Estimates & Trend Analysis

• 4.1. Application Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Tendon Repair Market by Application Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Rotator Cuff Repair
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Achilles Tendinosis Repair
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Cruciate Ligaments Repair
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Biceps Tenodesis
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Tendon Repair Market: Product Type Estimates & Trend Analysis

• 5.1. Product Type Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global U.S. Tendon Repair Market by Product Type Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Implants
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Suture Anchor Devices
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Grafts
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Matrix/Scaffolds
    • 5.4.4.1. Tendon Repair Matrix/Scaffolds
    • 5.4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4.2. Tendon Protection Matrix/Scaffolds
    • 5.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Screws
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Others
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2023
  • 6.3.4. Integra LifeSciences
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Arthrex, Inc.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. TendoMend
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. DePuy Synthes, Inc.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. CONMED Corporation.
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Stryker
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. BioPro, Inc.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Parcus Medical (Anika Therapeutics, Inc.)
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Aevumed, Inc.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. Smith+Nephew.
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Product benchmarking
    • 6.3.13.4. Strategic initiatives
  • 6.3.14. Alafair Biosciences, Inc.
    • 6.3.14.1. Company overview
    • 6.3.14.2. Financial performance
    • 6.3.14.3. Product benchmarking
    • 6.3.14.4. Strategic initiatives
  • 6.3.15. Amniotics AB
    • 6.3.15.1. Company overview
    • 6.3.15.2. Financial performance
    • 6.3.15.3. Product benchmarking
    • 6.3.15.4. Strategic initiatives
  • 6.3.16. BioTissue
    • 6.3.16.1. Company overview
    • 6.3.16.2. Financial performance
    • 6.3.16.3. Product benchmarking
    • 6.3.16.4. Strategic initiatives
  • 6.3.17. MiMedx
    • 6.3.17.1. Company overview
    • 6.3.17.2. Financial performance
    • 6.3.17.3. Product benchmarking
    • 6.3.17.4. Strategic initiatives